Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Saving money before the holidays can help you enjoy the festivities without financial stress. Here are effective ways to prepare your budget.
17,936 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Bitcoin trades in a tight range as energy-driven inflation signals ease. Markets monitor whether the gas-price hangov...
Roughly 1 in 10 Medicare Advantage enrollees will lose their current plan for 2026 as insurers retreat from markets. ...
Is SpaceX a smarter buy than the Magnificent Seven it briefly rivaled in market value? This analysis weighs growth, p...
A biotech growth stock has surged 70% this year as it heads into pivotal phase 3 data and regulatory steps. Here’s wh...
Intel has surged about 570% in the last year, turning a sleepy chipmaker into a headline stock. This guide breaks dow...
A major insider sale at TransMedics grabbed attention after the stock slumped about 45%. This article dives into what...
Bitcoin led a broad sell-off, triggering over $600m liquidated hour across major contracts. ETH and XRP followed, as ...
Choosing between broad energy exposure and high-yield pipelines requires weighing costs, income, and risk. This guide...
When the Fed paused, a 72-year-old retired investor moved money from stocks to Treasuries for stability. The plan loo...
Investors are asking if one AI leader can justify a multibillion-dollar market cap shift. This guide breaks down what...
Investors are buzzing about a big quarter from Micron. In micron's explosive earnings report:, the company posted a p...